Watch VideoAnother major coronavirus vaccine trial has reached its final and biggest hurdle.
British drugmaker AstraZeneca's vaccine candidate is now the third to start a Phase 3 trial in the U.S. That means it's in its final stage of testing.
It was developed in partnership with Oxford University.
The company says the...
Third Major Vaccine Candidate Starting Phase 3 Trial In U.S.
Newsy
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: ION Energy, Mirasol Resources, American Manganese, Lucky Minerals, Namaste Technologies, Water Tower Research, OTC Markets Group UPDATE...
Proactive Investors
ION Energy (CVE: ION) virtually opened the TSX Venture Exchange on Monday, September 28, having newly listed on the index. Chief..
-
NA Proactive news snapshot: OTC Markets Group, Phunware, Great Bear Resources, Chemistree Technology, Gold Resource Corporation, Bam Bam Resources, QC Copper and Gold UPDATE...
Proactive Investors
-
Bharat Biotech inks deal with Washington varsity for intranasal COVID-19 vax
Mid-Day
-
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day
-
COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan
Mid-Day
Advertisement
More coverage
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Mid-Day
Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical..
-
NA Proactive news snapshot: Aequus Pharmaceuticals, Thunderbird Entertainment, American Manganese, Energy Fuels UPDATE ...
Proactive Investors
-
Coronavirus outbreak: Serum Institute pauses COVID-19 vaccine trials in India
Mid-Day
-
Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK
Mid-Day
-
Asia Today: India has record spike of 95K new virus cases
SeattlePI.com